ex-vivo cell expansion

Suppliers: 1
States & provinces: 1
Countries: 1

1 ex-vivo cell expansion supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) is a clinical-stage biotechnology company focused on developing autologous cellular therapeutics for neurodegenerative diseases. Its proprietary NurOwn platform uses autologous mesenchymal stem cells to produce neurotrophic factor-secreting (MSC-NTF) cells, manufactured individually from each patient's bone marrow and delivered intrathecally. The company also has an allogeneic exosome platform.

autologous cell therapybone marrow harvesting and MSC isolationcell differentiationcryopreservationexosome platform developmentintrathecal administrationMSC-NTF cell production

Related capabilities

Other processes offered by the shops that list ex-vivo cell expansion.

autologous cell therapy (1)
bone marrow harvesting and MSC isolation (1)
cell differentiation (1)
cryopreservation (1)
exosome platform development (1)
intrathecal administration (1)
MSC-NTF cell production (1)

Browse all capabilities

ex-vivo cell expansion

Suppliers

BRAINSTORM CELL THERAPEUTICS INC

Related capabilities